INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Government Issues GOV
Contacted Congressional offices regarding State Department programs for vaccine clinical trials, and to obtain letters of support for Aduro's competitive grant applications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Defense DEF
H.R. 1540, National Defense Authorization Act, 2012, Title II, all provisions relating to infectious disease vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Budget/Appropriations BUD
H.R.2055, Consolidated Appropriations Act, 2012, Division A, Department of Defense Appropriations Act, 2012, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| JOHN LITTLE | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.